Corrigendum to ¿Clinical characteristics and survival outcomes of young women with luminal HER2-low and HER2-ultralow breast cancer¿ [Cancer Research and Treatment Communications 46 (2026) 101112] Academic Article in Scopus uri icon

abstract

  • DOI of original article: https://doi.org/10.1016/j.ctarc.2026.101112The authors acknowledge AstraZeneca for its sponsorship of this project. The authors regret Dr. Paula Cabrera-Galeana was unintentionally omitted from the author list in the published version of this article. Dr. Paula Cabrera-Galeana participated in the conceptualization, project administration, resources, and reviewed and edited the manuscript. The authors confirm and agree to this correction. This correction does not affect the scientific content, results, or conclusions of the article. The correct order of authors is as follows:

publication date

  • January 1, 2026